ImpACT+, a coping intervention to improve clinical outcomes for women living with HIV and sexual trauma in South Africa: study protocol for a randomized controlled trial.
Adherence
Antiretroviral therapy
HIV
Randomized controlled trial
Sexual violence
South Africa
Traumatic stress
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
18 Aug 2022
18 Aug 2022
Historique:
received:
15
06
2022
accepted:
09
08
2022
entrez:
18
8
2022
pubmed:
19
8
2022
medline:
23
8
2022
Statut:
epublish
Résumé
Addressing sexual trauma in the context of HIV care is essential to improve clinical outcomes and mental health among women in South Africa. Women living with HIV (WLH) report disproportionately high levels of sexual trauma and have higher rates of posttraumatic stress disorder. Adherence to antiretroviral therapy (ART) may be difficult for traumatized women, as sexual trauma compounds the stress associated with managing HIV and is often comorbid with other mental health disorders, further compromising care engagement and adherence. ART initiation represents a unique window of opportunity for intervention to enhance motivation, increase care engagement, and address the negative effects of trauma on avoidant coping behaviors. Mental health interventions delivered by non-specialists in low- and middle-income countries have potential to treat depression, trauma, and effects of intimate partner violence among WLH. This study will examine the effectiveness of Improving AIDS Care after Trauma (ImpACT +), a task-shared, trauma-focused coping intervention, to promote viral suppression among WLH initiating ART in a South African clinic setting. This study will be conducted in Khayelitsha, a peri-urban settlement situated near Cape Town, South Africa. Using a hybrid type 1 effectiveness-implementation design, we will randomize 350 WLH initiating ART to the ImpACT + experimental condition or the control condition (three weekly sessions of adapted problem-solving therapy) to examine the effectiveness of ImpACT + on viral suppression, ART adherence, and the degree to which mental health outcomes mediate intervention effects. ImpACT + participants will receive six once-a-week coping intervention sessions and six monthly maintenance sessions over the follow-up period. We will conduct mental health and bio-behavioral assessments at baseline, 4, 8, and 12 months, with care engagement data extracted from medical records. We will explore scalability using the Consolidated Framework for Implementation Research (CFIR). This trial is expected to yield important new information on psychologically informed intervention models that benefit the mental health and clinical outcomes of WLH with histories of sexual trauma. The proposed ImpACT + intervention, with its focus on building coping skills to address traumatic stress and engagement in HIV care and treatment, could have widespread impact on the health and wellbeing of individuals and communities in sub-Saharan Africa. Clinicaltrials.gov NCT04793217 . Retrospectively registered on 11 March 2021.
Sections du résumé
BACKGROUND
BACKGROUND
Addressing sexual trauma in the context of HIV care is essential to improve clinical outcomes and mental health among women in South Africa. Women living with HIV (WLH) report disproportionately high levels of sexual trauma and have higher rates of posttraumatic stress disorder. Adherence to antiretroviral therapy (ART) may be difficult for traumatized women, as sexual trauma compounds the stress associated with managing HIV and is often comorbid with other mental health disorders, further compromising care engagement and adherence. ART initiation represents a unique window of opportunity for intervention to enhance motivation, increase care engagement, and address the negative effects of trauma on avoidant coping behaviors. Mental health interventions delivered by non-specialists in low- and middle-income countries have potential to treat depression, trauma, and effects of intimate partner violence among WLH. This study will examine the effectiveness of Improving AIDS Care after Trauma (ImpACT +), a task-shared, trauma-focused coping intervention, to promote viral suppression among WLH initiating ART in a South African clinic setting.
METHODS
METHODS
This study will be conducted in Khayelitsha, a peri-urban settlement situated near Cape Town, South Africa. Using a hybrid type 1 effectiveness-implementation design, we will randomize 350 WLH initiating ART to the ImpACT + experimental condition or the control condition (three weekly sessions of adapted problem-solving therapy) to examine the effectiveness of ImpACT + on viral suppression, ART adherence, and the degree to which mental health outcomes mediate intervention effects. ImpACT + participants will receive six once-a-week coping intervention sessions and six monthly maintenance sessions over the follow-up period. We will conduct mental health and bio-behavioral assessments at baseline, 4, 8, and 12 months, with care engagement data extracted from medical records. We will explore scalability using the Consolidated Framework for Implementation Research (CFIR).
DISCUSSION
CONCLUSIONS
This trial is expected to yield important new information on psychologically informed intervention models that benefit the mental health and clinical outcomes of WLH with histories of sexual trauma. The proposed ImpACT + intervention, with its focus on building coping skills to address traumatic stress and engagement in HIV care and treatment, could have widespread impact on the health and wellbeing of individuals and communities in sub-Saharan Africa.
TRIAL REGISTRATION
BACKGROUND
Clinicaltrials.gov NCT04793217 . Retrospectively registered on 11 March 2021.
Identifiants
pubmed: 35982485
doi: 10.1186/s13063-022-06655-5
pii: 10.1186/s13063-022-06655-5
pmc: PMC9386207
doi:
Banques de données
ClinicalTrials.gov
['NCT04793217']
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
680Subventions
Organisme : NIMH NIH HHS
ID : R01 MH118004
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH118004
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Eval Program Plann. 2018 Jun;68:148-156
pubmed: 29597104
J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):32-8
pubmed: 23714742
J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):506-13
pubmed: 18176319
J Assoc Nurses AIDS Care. 2013 Jul-Aug;24(4):355-67
pubmed: 23790278
Psychosom Med. 2003 Nov-Dec;65(6):1038-46
pubmed: 14645783
J Interpers Violence. 2011 Sep;26(14):2764-89
pubmed: 21156693
Patient Prefer Adherence. 2018 Oct 04;12:1997-2006
pubmed: 30323569
Int J Behav Med. 1997;4(1):92-100
pubmed: 16250744
Lancet. 2009 Sep 19;374(9694):1011-1022
pubmed: 19709732
Afr J AIDS Res. 2021 Jul;20(2):141-148
pubmed: 33985421
J Int AIDS Soc. 2019 Jun;22(6):e25295
pubmed: 31190460
Best Pract Res Clin Obstet Gynaecol. 2013 Feb;27(1):15-26
pubmed: 22975432
AIDS Patient Care STDS. 2006 Jun;20(6):418-28
pubmed: 16789855
Am J Epidemiol. 2004 Aug 1;160(3):230-9
pubmed: 15257996
AIDS Behav. 2017 Nov;21(11):3209-3218
pubmed: 27866288
Stat Methods Med Res. 2013 Dec;22(6):661-70
pubmed: 22072596
BMC Psychiatry. 2011 Sep 30;11:156
pubmed: 21961801
AIDS Care. 2000 Jun;12(3):255-66
pubmed: 10928201
CNS Drugs. 2005;19(5):411-27
pubmed: 15907152
N Engl J Med. 2013 Jun 6;368(23):2182-91
pubmed: 23738545
AIDS Behav. 2018 Mar;22(3):929-938
pubmed: 28265805
S Afr Med J. 2001 May;91(5):421-8
pubmed: 11455808
AIDS. 2017 Feb 20;31(4):545-552
pubmed: 28121668
Am J Psychiatry. 2007 Nov;164(11):1707-13
pubmed: 17974936
Annu Rev Psychol. 2015 Jan 3;66:825-52
pubmed: 25148853
Curr HIV/AIDS Rep. 2011 Dec;8(4):215-22
pubmed: 21822626
Health Psychol. 2018 Jun;37(6):574-585
pubmed: 29781655
BJPsych Open. 2019 Aug 06;5(5):e69
pubmed: 31530322
PLoS Med. 2021 May 24;18(5):e1003651
pubmed: 34029346
Glob Ment Health (Camb). 2015;2:
pubmed: 28593049
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Am J Public Health. 2004 Jul;94(7):1147-51
pubmed: 15226135
AIDS Care. 2013;25(6):695-701
pubmed: 23442202
Int J Epidemiol. 2017 Apr 1;46(2):e21
pubmed: 27208042
J Abnorm Child Psychol. 2014;42(3):339-42
pubmed: 24414018
J Int Assoc Provid AIDS Care. 2021 Jan-Dec;20:2325958220985665
pubmed: 33472517
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
AIDS Care. 2004;16 Suppl 1:S97-120
pubmed: 15736824
Int J Ment Health Syst. 2020 Dec 3;14(1):89
pubmed: 33292389
S Afr Med J. 2003 Dec;93(12):928-31
pubmed: 14750493
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
Curr HIV/AIDS Rep. 2012 Dec;9(4):344-50
pubmed: 23007792
AIDS. 2015 Oct 23;29(16):2183-94
pubmed: 26353027
J Consult Clin Psychol. 2013 Apr;81(2):274-83
pubmed: 23025248
J Health Psychol. 2013 Feb;18(2):198-211
pubmed: 22453164
AIDS Behav. 2007 Jan;11(1):49-60
pubmed: 16858634
AIDS Behav. 2012 Nov;16(8):2091-100
pubmed: 22249954
AIDS Behav. 2016 Nov;20(11):2700-2708
pubmed: 27098408
AIDS Care. 2008 Nov;20(10):1233-41
pubmed: 18608062
Subst Abuse Treat Prev Policy. 2015 Nov 14;10:46
pubmed: 26576946
Am J Psychiatry. 1999 Jun;156(6):908-11
pubmed: 10360131
Evid Based Ment Health. 2018 Feb;21(1):30-34
pubmed: 28903977
J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):1-2
pubmed: 23846571
Addiction. 2010 Nov;105(11):1942-51
pubmed: 20840176
AIDS Patient Care STDS. 2008 Feb;22(2):147-58
pubmed: 18260806
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):409-16
pubmed: 22107822
Int J Environ Res Public Health. 2020 Mar 27;17(7):
pubmed: 32230712
J Int AIDS Soc. 2021 Jun;24 Suppl 2:e25722
pubmed: 34164926
Lancet Psychiatry. 2018 Apr;5(4):357-369
pubmed: 29580610
AIDS Care. 2018 Apr;30(4):399-408
pubmed: 29397777
Trop Med Int Health. 2016 Oct;21(10):1198-1208
pubmed: 27443803
AIDS Behav. 2010 Apr;14(2):252-62
pubmed: 20013043
AIDS Care. 2000 Oct;12(5):567-80
pubmed: 11218543
Soc Sci Med. 1988;26(3):309-17
pubmed: 3279520
Gen Hosp Psychiatry. 2001 Sep-Oct;23(5):294-6
pubmed: 11600172
AIDS Behav. 2018 Mar;22(3):1039-1052
pubmed: 29270789
AIDS Behav. 2022 May;26(5):1517-1529
pubmed: 34686946
AIDS Behav. 2011 Jan;15(1):125-31
pubmed: 19082880
PLoS Med. 2021 Jan 11;18(1):e1003468
pubmed: 33428625
Soc Sci Med. 2002 Oct;55(7):1231-44
pubmed: 12365533
Curr HIV/AIDS Rep. 2015 Dec;12(4):397-405
pubmed: 26419376
AIDS Behav. 2018 Oct;22(10):3155-3165
pubmed: 29476437
Nurs Res. 2011 Jul-Aug;60(4):264-9
pubmed: 21677597
J Int AIDS Soc. 2021 Oct;24(10):e25823
pubmed: 34708929